Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disorder in the Human Skp1 Structure is the Key to its Adaptability to Bind Many Different Proteins in the SCF Complex Assembly. | J Mol Biol | 2022 | 36116539 | PubTator, text mining | PubMed |
| PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. | Oncogenesis | 2022 | 36115843 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis: Evidence from interaction analysis. | Front Endocrinol (Lausanne) | 2022 | 36105405 | PubTator, text mining | PubMed |
| FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer. | J Immunother Cancer | 2022 | 36104103 | PubTator, text mining | PubMed |
| The relationship of alpha-synuclein to mitochondrial dynamics and quality control. | Front Mol Neurosci | 2022 | 36090250 | PubTator, text mining | PubMed |
| Promising anticancer activities and mechanisms of action of active compounds from the medicinal herb Centipeda minima (L.) A. Braun & Asch. | Phytomedicine | 2022 | 36084403 | PubTator, text mining | PubMed |
| NEDD4 E3 Ligases: Functions and Mechanisms in Bone and Tooth. | Int J Mol Sci | 2022 | 36077334 | PubTator, text mining | PubMed |
| The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. | J Hematol Oncol | 2022 | 36076302 | PubTator, text mining | PubMed |
| Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast-Myofibroblast Transformation against Pulmonary Fibrosis. | ACS Chem Biol | 2022 | 36076154 | PubTator, text mining | PubMed |
| ReDisX, a machine learning approach, rationalizes rheumatoid arthritis and coronary artery disease patients uniquely upon identifying subpopulation differentiation markers from their genomic data. | Front Med (Lausanne) | 2022 | 36072953 | PubTator, text mining | PubMed |
| Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors. | Front Pharmacol | 2022 | 36071844 | PubTator, text mining | PubMed |
| ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC. | Front Oncol | 2022 | 36059676 | PubTator, text mining | PubMed |
| Degradation strategy of cyclin D1 in cancer cells and the potential clinical application. | Front Oncol | 2022 | 36059670 | PubTator, text mining | PubMed |
| An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases. | Front Immunol | 2022 | 36059474 | PubTator, text mining | PubMed |
| Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it. | Explor Target Antitumor Ther | 2022 | 36045907 | PubTator, text mining | PubMed |
| Extracellular matrix stiffness regulates degradation of MST2 via SCF βTrCP. | Biochim Biophys Acta Gen Subj | 2022 | 36044955 | PubTator, text mining | PubMed |
| Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication. | Proc Natl Acad Sci U S A | 2022 | 36037385 | PubTator, text mining | PubMed |
| FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells. | Int J Med Sci | 2022 | 36035375 | PubTator, text mining | PubMed |
| Editorial: Exploring the subcellular proteome and its post-translational modifications. | Front Mol Biosci | 2022 | 36032683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=33